SLNSW-Differential Activity of Nivolumab, Pembrolizumab...-TN_cdi_plos_journals_1689845787

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

Full title: Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

Author/creator: Carbognin, Luisa, Pilotto, Sara, Milella, Michele, Vaccaro, Vanja, Brunelli, Matteo, Caliò, Anna, Cuppone, Federica, Sperduti, Isabella, Giannarelli, Diana, Chilosi, Marco, Bronte, Vincenzo, Scarpa, Aldo, Bria, Emilio, Tortora, Giampaolo.

Call Numbers:

Record Identifier: TN_cdi_plos_journals_1689845787

Language: English

Formats: Articles

Publishers: United States: Public Library of Science

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1689845787

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

    Record identifier

    TN_cdi_plos_journals_1689845787

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1689845787

    Share

    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1689845787

    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

    Full title

    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

    Author / Creator

    Carbognin, Luisa ; Pilotto, Sara ; Milella, Michele ; Vaccaro, Vanja ; Brunelli, Matteo ; Caliò, Anna ; Cuppone, Federica ; Sperduti, Isabella ; Giannarelli, Diana ; Chilosi, Marco ; Bronte, Vincenzo ; Scarpa, Aldo ; Bria, Emilio ; Tortora, Giampaolo

    Publisher

    United States: Public Library of Science

    Journal title

    PloS one, 2015, Vol.10 (6), p.e0130142-e0130142

    Record Identifier

    TN_cdi_plos_journals_1689845787

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Antibodies Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - therapeutic use Apoptosis B7-H1 Antigen - genetics Biomarkers Blood diseases Cancer Cancer therapies Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Care and treatment Clinical trials Confidence intervals Gene Expression Regulation, Neoplastic Humans Immune checkpoint Immunotherapy Ligands Lung - drug effects Lung - metabolism Lung - pathology Lung cancer Lung cancer, Non-small cell Lung diseases Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Lung Neoplasms - genetics Medical prognosis Melanoma Melanoma - diagnosis Melanoma - drug therapy Melanoma - genetics Monoclonal antibodies Mutation Neoplasms - diagnosis Neoplasms - drug therapy Neoplasms - genetics Non-small cell lung carcinoma Oncology Pathology Patients PD-1 protein PD-L1 protein Prognosis Sensitivity analysis Solid tumors Targeted cancer therapy Treatment Outcome Tumor cells Tumors Urogenital Neoplasms - diagnosis Urogenital Neoplasms - drug therapy Urogenital Neoplasms - genetics Urogenital System - drug effects Urogenital System - metabolism Urogenital System - pathology

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_plos_journals_1689845787

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1689845787

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections